Prof. Kang's phase 3 study on Nexava attracting world interests.

Published: 2006-10-26 06:57:00

Updated: 2006-10-26 06:57:00

Prof. Kang Yun-kyu, the oncologist of Seoul Asan Hospital who was reputed with the anti-cancer drug therapy presented his paper titled "A new paradigm of anti-cancer therapy" covering his clinical studies on Nexava, an anti-cancer drug, on Oct. 13 during the conference of PSMO (The Philippine Society of Medica Oncologists) as an invited lecturer

In about 130 of oncology expert attendance to ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.